Laura Diekman

1.8k total citations · 1 hit paper
18 papers, 766 citations indexed

About

Laura Diekman is a scholar working on Rheumatology, Immunology and Pharmacology. According to data from OpenAlex, Laura Diekman has authored 18 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 5 papers in Immunology and 3 papers in Pharmacology. Recurrent topics in Laura Diekman's work include Spondyloarthritis Studies and Treatments (11 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). Laura Diekman is often cited by papers focused on Spondyloarthritis Studies and Treatments (11 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). Laura Diekman collaborates with scholars based in United States, Australia and Canada. Laura Diekman's co-authors include John C. Davis, M. Mack, Joachim Sieper, Anna Beutler, Robert D. Inman, Sudha Visvanathan, Jürgen Braun, Désirée van der Heijde, Zhenhua Xu and Benjamin Hsu and has published in prestigious journals such as Annals of the Rheumatic Diseases, Archives of Biochemistry and Biophysics and BMC Medical Research Methodology.

In The Last Decade

Laura Diekman

16 papers receiving 745 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial

2008 444 citations Robert D. Inman, John C. Davis et al. Arthritis & Rheumatism profile →

Peers

Countries citing papers authored by Laura Diekman

Since Specialization

Citations

This map shows the geographic impact of Laura Diekman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Diekman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Diekman more than expected).

Fields of papers citing papers by Laura Diekman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Diekman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Diekman. The network helps show where Laura Diekman may publish in the future.

Co-authorship network of co-authors of Laura Diekman

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Diekman. A scholar is included among the top collaborators of Laura Diekman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Diekman. Laura Diekman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	The changing profile of ankylosing spondylitis in the biologic era 2020 ·Clinical Rheumatology ·John D. Reveille, MinJae Lee, Lianne S. Gensler, Michael M. Ward, Mark C. Hwang, Thomas J. Learch, Amirali Tahanan, Laura Diekman, Mohammad H. Rahbar, Mariko Ishimori, Michael H. Weisman	4
2	Chronic back pain in first-degree relatives (FDRs) of patients with ankylosing spondylitis: predictive value of HLA-B27 and persistence of inflammatory back pain over time 2020 ·RMD Open ·(unknown), Michael H. Weisman, Michael M. Ward, Lianne S. Gensler, Mariko Ishimori, Amirali Tahanan, David Chenho Kung, Laura Diekman, MinJae Lee, Mohammad H. Rahbar, John D. Reveille	4
3	Harmonization, data management, and statistical issues related to prospective multicenter studies in Ankylosing spondylitis (AS): Experience from the Prospective Study Of Ankylosing Spondylitis (PSOAS) cohort 2018 ·Contemporary Clinical Trials Communications ·Mohammad H. Rahbar, MinJae Lee, Manouchehr Hessabi, Amirali Tahanan, Matthew A. Brown, Thomas J. Learch, Laura Diekman, Michael H. Weisman, John D. Reveille	17
4	A multiple imputation method based on weighted quantile regression models for longitudinal censored biomarker data with missing values at early visits 2018 ·BMC Medical Research Methodology ·MinJae Lee, Mohammad H. Rahbar, Matthew A. Brown, Lianne S. Gensler, Michael H. Weisman, Laura Diekman, John D. Reveille	11
5	Opioid Analgesic Use in Patients with Ankylosing Spondylitis: An Analysis of the Prospective Study of Outcomes in an Ankylosing Spondylitis Cohort 2017 ·The Journal of Rheumatology ·Jonathan Dau, MinJae Lee, Michael M. Ward, Lianne S. Gensler, Matthew A. Brown, Thomas J. Learch, Laura Diekman, Amirali Tahanan, Mohammad H. Rahbar, Michael H. Weisman, John D. Reveille	21
6	Ethnicity and disease severity in ankylosing spondylitis a cross-sectional analysis of three ethnic groups 2017 ·Clinical Rheumatology ·(unknown), Michael M. Ward, Shervin Assassi, Thomas J. Learch, MinJae Lee, Lianne S. Gensler, Matthew A. Brown, Laura Diekman, Amirali Tahanan, Mohammad H. Rahbar, Michael H. Weisman, John D. Reveille	31
7	SAT0400 Clinical Factors Impacting Statin Usage in A Longitudinal Ankylosing Spondylitis Cohort 2016 ·Annals of the Rheumatic Diseases ·Jonathan Dau, M H Weisman, (unknown), Michael M. Ward, Matthew A. Brown, Laura Diekman, Mohammad H. Rahbar, Lianne S. Gensler, John D. Reveille	0
8	Factors associated with anti-TNF treatment in a longitudinally followed ankylosing spondylitis (AS) cohort 2015 ·Queensland's institutional digital repository (The University of Queensland) ·Mary Gibson, MinJae Lee, Michael M. Ward, Lianne S. Gensler, Matthew A. Brown, Shervin Assassi, (unknown), Laura Diekman, Mohammad H. Rahbar, Michael H. Weisman, John D. Reveille	0
9	New Population‐Based Reference Values for Spinal Mobility Measures Based on the 2009–2010 National Health and Nutrition Examination Survey 2014 ·Arthritis & Rheumatology ·Shervin Assassi, Michael H. Weisman, MinJae Lee, Laurie Savage, Laura Diekman, (unknown), Mohammad H. Rahbar, Joan I. Schall, Lianne S. Gensler, Atul Deodhar, Daniel O. Clegg, Robert A. Colbert, John D. Reveille	11
10	GOLIMUMAB, A NEW HUMAN TNF-alpha ANTIBODY ADMINISTERED SUBCUTANEOUSLY EVERY 4 WEEKS, IN ANKYLOSING SPONDYLITIS : 104-WEEK EFFICACY AND SAFETY RESULTS OF THE RANDOMIZED, PLACEBO-CONTROLLED GO-RAISE STUDY 2010 ·Clinical and Experimental Rheumatology ·(unknown), D. van der Heijde, Atul Deodhar, Laura Diekman, Joachim Sieper, (unknown), Anna Beutler, M. Mack, Shancai Xu, Julie Zrubek, Benjumin Hsu, Robert D. Inman, (unknown)	6
11	Psychological Correlates of Self-reported Disease Activity in Ankylosing Spondylitis 2010 ·The Journal of Rheumatology ·(unknown), Shervin Assassi, John D. Reveille, Charles Green, Thomas J. Learch, Laura Diekman, Michael M. Ward, John C. Davis, Michael H. Weisman, Perry M. Nicassio	36
12	Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations 2009 ·Arthritis Research & Therapy ·Pravitt Gourh, Frank C. Arnett, Shervin Assassi, Filemon K. Tan, Mei Huang, Laura Diekman, Maureen D. Mayes, John D. Reveille, Sandeep K. Agarwal	121
13	Psychological correlates of self-reported functional limitation in patients with ankylosing spondylitis 2009 ·Arthritis Research & Therapy ·(unknown), Shervin Assassi, John D. Reveille, Thomas J. Learch, Laura Diekman, Michael M. Ward, John C. Davis, Michael H. Weisman, Perry M. Nicassio	48
14	Genomewide association study in Ankylosing spondylitis identifies major Non-MHC genetic determinants of disease susceptibility 2008 ·Clinical and Experimental Rheumatology ·John D. Reveille, (unknown), Walter P. Maksymowych, Michael M. Ward, Millicent Stone, (unknown), Michael H. Weisman, Robert D. Inman, Dafna D. Gladman, (unknown), Thomas J. Learch, Laurie Savage, Laura Diekman, Patrick Danoy, J J Pointon, Xiaofeng Zhou, David M. Evans, B. P. Wordsworth, Matthew A. Brown	2
15	Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial breakdown → 2008 ·Arthritis & Rheumatism ·Robert D. Inman, John C. Davis, Désirée van der Heijde, Laura Diekman, Joachim Sieper, (unknown), M. Mack, John Han, Sudha Visvanathan, Zhenhua Xu, Benjamin Hsu, Anna Beutler, Jürgen Braun	444
16	The MHC Class II Haplotype HLA–DRB10801/DQA10401/DQB1*0402 Is Associated With Acute Anterior Uveitis 2005 ·Friederike Mackensen, John D. Reveille, Justine R. Smith, (unknown), Laura Diekman, Trudy M. Doyle, (unknown), (unknown), J. T. Rosenbaum, Tammy M. Martin	2
17	Frequency of HLA-DQB06* in Caucasian, African American, and Mexican American patients with a positive direct antiglobulin test 2000 ·Immunohematology ·Laura Diekman, (unknown), John D. Reveille, (unknown)	1
18	Comparison of Prostaglandin H Synthase Isoform Structures Using Limited Proteolytic Digestion 1997 ·Archives of Biochemistry and Biophysics ·(unknown), (unknown), Laura Diekman, Guishan Xiao, Richard J. Kulmacz	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact